Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1214717 BOSTON, MA

Position in LGND

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$111,591,172
+$18,268,301 QoQ
Shares Held
558,934
+13.2% QoQ
Ownership
2.79%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. LGND ranks #36 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LGND

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $111,591,172 558,934
2025-12-31 $93,322,871 493,589
2025-09-30 $83,997,839 474,189
2025-06-30 $55,564,282 488,778
2025-03-31 $48,832,483 464,452
2024-12-31 $46,978,953 438,441
2024-09-30 $42,865,544 428,270
2024-06-30 $34,190,600 405,775
2024-03-31 $27,848,907 380,970
2023-12-31 $26,483,607 370,815
2023-09-30 $21,129,050 352,621
2023-06-30 $24,630,297 341,613
2023-03-31 $23,303,734 316,799
2022-12-31 $20,084,756 300,670
2022-09-30 $15,584,128 290,110
2022-06-30 $16,181,201 290,725
2022-03-31 $21,094,304 300,597
2021-12-31 $27,429,215 284,663
2021-09-30 $23,989,015 276,015
2021-06-30 $22,715,593 277,560
2021-03-31 $25,000,269 262,876
2020-12-31 $14,505,362 233,807
2020-09-30 $13,785,779 231,836
2020-06-30 $16,807,707 240,883
2020-03-31 $11,786,844 259,823